rs6728344

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000644224.2(SLC19A3):​c.-2-10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,613,316 control chromosomes in the GnomAD database, including 588 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 265 hom., cov: 32)
Exomes 𝑓: 0.012 ( 323 hom. )

Consequence

SLC19A3
ENST00000644224.2 intron

Scores

2
Splicing: ADA: 0.00005165
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.546

Publications

1 publications found
Variant links:
Genes affected
SLC19A3 (HGNC:16266): (solute carrier family 19 member 3) This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild cognitive disability, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.[provided by RefSeq, Jan 2010]
SLC19A3 Gene-Disease associations (from GenCC):
  • biotin-responsive basal ganglia disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • infantile spams-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 2-227702330-T-C is Benign according to our data. Variant chr2-227702330-T-C is described in ClinVar as Benign. ClinVar VariationId is 139122.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000644224.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC19A3
NM_025243.4
MANE Select
c.-2-10A>G
intron
N/ANP_079519.1
SLC19A3
NM_001371411.1
c.-2-10A>G
intron
N/ANP_001358340.1
SLC19A3
NM_001371412.1
c.-2-10A>G
intron
N/ANP_001358341.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC19A3
ENST00000419059.1
TSL:1
c.-12A>G
5_prime_UTR
Exon 1 of 2ENSP00000398349.1
SLC19A3
ENST00000644224.2
MANE Select
c.-2-10A>G
intron
N/AENSP00000495385.1
SLC19A3
ENST00000258403.8
TSL:1
c.-2-10A>G
intron
N/AENSP00000258403.3

Frequencies

GnomAD3 genomes
AF:
0.0370
AC:
5620
AN:
151766
Hom.:
264
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.109
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0170
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00498
Gnomad FIN
AF:
0.000285
Gnomad MID
AF:
0.0288
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.0327
GnomAD2 exomes
AF:
0.0153
AC:
3840
AN:
251086
AF XY:
0.0133
show subpopulations
Gnomad AFR exome
AF:
0.115
Gnomad AMR exome
AF:
0.0102
Gnomad ASJ exome
AF:
0.00348
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.0134
GnomAD4 exome
AF:
0.0122
AC:
17837
AN:
1461446
Hom.:
323
Cov.:
31
AF XY:
0.0115
AC XY:
8360
AN XY:
727042
show subpopulations
African (AFR)
AF:
0.114
AC:
3812
AN:
33440
American (AMR)
AF:
0.0107
AC:
479
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00406
AC:
106
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39684
South Asian (SAS)
AF:
0.00423
AC:
365
AN:
86252
European-Finnish (FIN)
AF:
0.00156
AC:
83
AN:
53310
Middle Eastern (MID)
AF:
0.0199
AC:
115
AN:
5768
European-Non Finnish (NFE)
AF:
0.0107
AC:
11933
AN:
1111754
Other (OTH)
AF:
0.0156
AC:
943
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
757
1514
2272
3029
3786
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
500
1000
1500
2000
2500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0371
AC:
5634
AN:
151870
Hom.:
265
Cov.:
32
AF XY:
0.0367
AC XY:
2726
AN XY:
74196
show subpopulations
African (AFR)
AF:
0.109
AC:
4508
AN:
41394
American (AMR)
AF:
0.0169
AC:
258
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00499
AC:
24
AN:
4812
European-Finnish (FIN)
AF:
0.000285
AC:
3
AN:
10514
Middle Eastern (MID)
AF:
0.0313
AC:
9
AN:
288
European-Non Finnish (NFE)
AF:
0.0111
AC:
758
AN:
67992
Other (OTH)
AF:
0.0328
AC:
69
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
252
503
755
1006
1258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0239
Hom.:
39
Bravo
AF:
0.0424
Asia WGS
AF:
0.0120
AC:
41
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Biotin-responsive basal ganglia disease (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
1.6
DANN
Benign
0.73
PhyloP100
-0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000052
dbscSNV1_RF
Benign
0.076
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6728344; hg19: chr2-228567046; API